TRACON PHARMACEUTICALS INC's ticker is TCON and the CUSIP is 89237H100. A total of 39 filers reported holding TRACON PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $811,000 | -47.7% | 346,718 | -90.0% | 0.04% | -70.3% |
Q3 2019 | $1,550,000 | -34.3% | 3,467,181 | 0.0% | 0.13% | -22.4% |
Q2 2019 | $2,358,000 | -50.4% | 3,467,181 | 0.0% | 0.16% | -33.2% |
Q1 2019 | $4,750,000 | +117.5% | 3,467,181 | 0.0% | 0.25% | +183.9% |
Q4 2018 | $2,184,000 | -69.3% | 3,467,181 | 0.0% | 0.09% | -71.7% |
Q3 2018 | $7,108,000 | -24.1% | 3,467,181 | 0.0% | 0.31% | -30.1% |
Q2 2018 | $9,361,000 | +17.4% | 3,467,181 | 0.0% | 0.44% | +23.7% |
Q1 2018 | $7,975,000 | -13.7% | 3,467,181 | +25.7% | 0.36% | -7.3% |
Q4 2017 | $9,243,000 | +6.3% | 2,759,217 | 0.0% | 0.38% | +26.0% |
Q3 2017 | $8,692,000 | +31.3% | 2,759,217 | 0.0% | 0.30% | +26.1% |
Q2 2017 | $6,622,000 | -36.0% | 2,759,217 | 0.0% | 0.24% | -33.1% |
Q1 2017 | $10,347,000 | -23.5% | 2,759,217 | 0.0% | 0.36% | -33.1% |
Q4 2016 | $13,520,000 | +7.3% | 2,759,217 | +46.0% | 0.54% | -4.9% |
Q3 2016 | $12,604,000 | +52.3% | 1,889,652 | 0.0% | 0.57% | +31.6% |
Q2 2016 | $8,277,000 | -37.3% | 1,889,652 | 0.0% | 0.43% | -51.0% |
Q1 2016 | $13,209,000 | -24.3% | 1,889,652 | 0.0% | 0.88% | -21.1% |
Q4 2015 | $17,460,000 | -5.4% | 1,889,652 | 0.0% | 1.11% | -8.6% |
Q3 2015 | $18,462,000 | -13.8% | 1,889,652 | 0.0% | 1.22% | +8.8% |
Q2 2015 | $21,410,000 | -19.3% | 1,889,652 | 0.0% | 1.12% | -6.8% |
Q1 2015 | $26,531,000 | – | 1,889,652 | – | 1.20% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Puissance Capital Management LP | 76,048 | $178,000 | 0.44% |
NEA Management Company, LLC | 346,718 | $811,000 | 0.04% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |